ROMAGNANI, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 20.768
EU - Europa 13.108
AS - Asia 9.101
SA - Sud America 1.323
AF - Africa 355
Continente sconosciuto - Info sul continente non disponibili 294
OC - Oceania 256
Totale 45.205
Nazione #
US - Stati Uniti d'America 20.243
RU - Federazione Russa 4.234
IT - Italia 2.971
SG - Singapore 2.634
CN - Cina 2.105
HK - Hong Kong 1.310
PL - Polonia 1.113
BR - Brasile 1.023
SE - Svezia 977
VN - Vietnam 950
IE - Irlanda 947
KR - Corea 673
DE - Germania 601
FI - Finlandia 471
FR - Francia 429
UA - Ucraina 396
GB - Regno Unito 356
CA - Canada 354
IN - India 336
AU - Australia 250
BD - Bangladesh 193
CH - Svizzera 146
JP - Giappone 141
JO - Giordania 126
ID - Indonesia 121
NL - Olanda 115
IQ - Iraq 99
ES - Italia 96
MX - Messico 86
AR - Argentina 85
ZA - Sudafrica 85
TR - Turchia 82
NG - Nigeria 62
BE - Belgio 51
PK - Pakistan 48
CL - Cile 45
CO - Colombia 44
CI - Costa d'Avorio 42
AT - Austria 40
EC - Ecuador 39
DK - Danimarca 26
EG - Egitto 26
VE - Venezuela 26
TW - Taiwan 25
IL - Israele 24
RO - Romania 24
DZ - Algeria 23
MA - Marocco 23
PH - Filippine 23
PE - Perù 22
SA - Arabia Saudita 21
CR - Costa Rica 19
PY - Paraguay 19
MY - Malesia 18
UZ - Uzbekistan 18
AE - Emirati Arabi Uniti 16
GR - Grecia 16
KE - Kenya 16
KZ - Kazakistan 15
TH - Thailandia 15
ET - Etiopia 14
SC - Seychelles 14
BG - Bulgaria 13
CZ - Repubblica Ceca 13
IR - Iran 13
LB - Libano 13
NP - Nepal 13
TN - Tunisia 11
UY - Uruguay 11
LT - Lituania 10
MT - Malta 10
TT - Trinidad e Tobago 10
JM - Giamaica 9
AZ - Azerbaigian 8
BO - Bolivia 8
GH - Ghana 8
YE - Yemen 8
HR - Croazia 7
MU - Mauritius 7
AL - Albania 6
BJ - Benin 6
EU - Europa 6
GT - Guatemala 6
KG - Kirghizistan 6
NZ - Nuova Zelanda 6
OM - Oman 6
PR - Porto Rico 6
SN - Senegal 6
SV - El Salvador 6
SY - Repubblica araba siriana 6
AM - Armenia 5
BB - Barbados 5
DO - Repubblica Dominicana 5
LU - Lussemburgo 5
MK - Macedonia 5
NI - Nicaragua 5
PS - Palestinian Territory 5
QA - Qatar 5
HU - Ungheria 4
LA - Repubblica Popolare Democratica del Laos 4
Totale 44.848
Città #
Santa Clara 3.646
Ashburn 2.352
Singapore 1.847
Fairfield 1.740
Warsaw 1.098
Hong Kong 1.022
Chandler 967
Dublin 946
Woodbridge 780
Seattle 721
San Jose 672
Cambridge 671
Houston 657
Seoul 651
Jacksonville 633
Wilmington 527
Milan 502
Beijing 440
Council Bluffs 434
Ann Arbor 398
Hefei 342
Florence 324
Altamura 307
The Dalles 307
Los Angeles 301
Ho Chi Minh City 290
Lawrence 278
Princeton 272
Buffalo 259
Rome 243
Lauterbourg 226
Hanoi 222
New York 211
Boston 209
Helsinki 200
Melbourne 178
Munich 177
Boardman 165
Mumbai 157
Moscow 154
Dallas 145
Bern 136
Shanghai 121
San Diego 116
Medford 104
Paris 100
São Paulo 95
Tokyo 95
Naples 75
Jakarta 69
Toronto 69
Kent 68
London 68
Frankfurt am Main 60
Turin 58
Chicago 57
Sydney 56
Norwalk 55
Bologna 54
Turku 53
Orem 51
Columbus 50
Montreal 50
Clifton 49
Guangzhou 48
Erbil 47
Falls Church 45
Dong Ket 43
Abidjan 42
Redondo Beach 42
Abuja 41
Da Nang 40
Brussels 39
Chennai 37
Izmir 37
Johannesburg 37
Figino 36
Hillsboro 35
Palermo 33
Phoenix 32
Vienna 32
Denver 31
Atlanta 30
Haiphong 30
Barcelona 29
Amsterdam 28
Lappeenranta 27
Bari 26
Brooklyn 26
Genoa 26
Porto Alegre 25
Rio de Janeiro 25
Tianjin 25
Verona 25
Cape Town 24
Hamilton 24
Shenzhen 24
Singen 24
Starkville 24
Baghdad 23
Totale 28.542
Nome #
Chronic kidney disease 1.697
Acute kidney injury promotes development of papillary renal cell adenoma and carcinoma from renal progenitor cells. 365
Endocycle-related tubular cell hypertrophy and progenitor proliferation recover renal function after acute kidney injury. 341
Differential expression of two isoforms of the chemokine receptor CXCR3 determines the ultimate effect of IP-10 on survival of human hepatic stellate cells (HSC) 323
Calcium-dependent activation of NF-kappa B by the adipokine resistin in hepatic stellate cells 310
Urinary [TIMP-2]/[IGFBP7] Ratio (Nephrocheck ® akiscore ®) as a biomarker of “subclinical” acute kidney injury after robotic partial nephrectomy 280
CXCL12 blockade preferentially regenerates lost podocytes in cortical nephrons by targeting an intrinsic podocyte-progenitor feedback mechanism 277
Mesenchymal Stem Cell-Based Therapy for Kidney Disease: A Review of Clinical Evidence 273
Differentiation of crescent-forming kidney progenitor cells into podocytes attenuates severe glomerulonephritis in mice 270
Surviving Acute Organ Failure: Cell Polyploidization and Progenitor Proliferation 266
Bioengineering strategies for nephrologists: kidney was not built in a day 265
Regeneration of Glomerular Podocytes by Human Renal Progenitors. 263
Podocyte Regeneration Driven by Renal Progenitors Determines Glomerular Disease Remission and Can Be Pharmacologically Enhanced 260
A Clinical Workflow for Cost-Saving High-Rate Diagnosis of Genetic Kidney Diseases 257
Can serum and urinary biomarkers predict acute kidney injury after robotic partial nephrectomy? a prospective feasibility study 257
Therapeutic efficacy of autologous non-mobilized enriched circulating endothelial progenitors in patients with critical limb ischemia ― The scelta trial 254
A developmental approach to the prevention of hypertension and kidney disease: a report from the Low Birth Weight and Nephron Number Working Group 252
Postoperative acute kidney injury in patients with papillary renal cell carcinoma as a novel risk factor for local recurrence. Results from a large multicentric, observational study (the record 1 project) 248
T cells and cytokines in Crohn’s disease. 246
HUMAN CD8+CD25+ THYMOCYTES SHARE PHENOTYPIC AND FUNCTIONAL FEATURES WITH CD4+CD25+ REGULATORY THYMOCYTES. 242
Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells. 242
Reverse phenotyping after whole-Exome sequencing in steroid-resistant nephrotic syndrome 241
SGLT2 inhibition requires reconsideration of fundamental paradigms in chronic kidney disease, 'diabetic nephropathy', IgA nephropathy and podocytopathies with FSGS lesions 237
NephroCheck™ and kinetic GFR as promising markers for the early detection of acute kidney injury after partial nephrectomy: Preliminary results from a single-centre prospective study 236
An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. 234
Substrate Stiffness Modulates Renal Progenitor Cell Properties via a ROCK-Mediated Mechanotransduction Mechanism 234
Inducible nitric oxide synthase expression in vascular and glomerular structures of human chronic allograft nephropathy. 229
Biologic modulation in renal regeneration 228
Molecular mechanisms of the acute kidney injury to chronic kidney disease transition: An updated view 227
Activation of p38(MAPK) mediates the angiostatic effect of the chemokine receptor CXCR3-B. 225
A Report of 2 Cases of Kidney Involvement in ADA2 Deficiency: Different Disease Phenotypes and the Tissue Response to Type I Interferon 222
Glomerular parietal epithelial cells in kidney physiology, pathology, and repair. 221
CD14+CD34(low) cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors 221
Isolation and characterization of multipotent progenitor cells from the Bowman's capsule of adult human kidneys 220
CXC chemokines: the regulatory link between inflammation and angiogenesis 219
Anti-fibrotic treatments: A review of clinical evidence 218
Regenerating the kidney using human pluripotent stem cells and renal progenitors 217
Asymptomatic Hyperuricemia Promotes Recovery from Ischemic Organ Injury by Modulating the Phenotype of Macrophages 213
Comparison between VDR analogs and current immunosuppressive drugs in relation to CXCL10 secretion by human renal tubular cells. 213
Phenotype, localization and mechanism of suppression of CD4+CD25+ human thymocytes. 212
Phenotypic and functional features of human Th17 cells 211
Anti-slit diaphragm antibodies on kidney biopsy identify pediatric patients with steroid-resistant nephrotic syndrome responsive to second-line immunosuppressants 210
Chronic kidney disease in children 210
CXCR3-binding chemokines: novel multifunctional therapeutic targets. 210
Co-cultures of renal progenitors and endothelial cells on kidney decellularized matrices replicate the renal tubular environment in vitro 210
The genetic and clinical spectrum of a large cohort of patients with distal renal tubular acidosis 210
Regenerative potential of embryonic renal multipotent progenitors in acute renal failure 210
Proteinuria impairs podocyte regeneration by sequestering retinoic acid. 207
Phenotypic and functional features of human Th17 cells 207
PF-4/CXCL4 and CXCLAL1 exhibit distinct subcellular localization and a differentially regulated mechanism of secretion 207
Frequency of regulatory T cells in peripheral blood and in tumour-infiltrating lymphocytes correlates with poor prognosis in renal cell carcinoma. 206
Renal Progenitor Cells Contribute to Hyperplastic Lesions of Podocytopathies and Crescentic Glomerulonephritis 204
Evaluation of different biomarkers for the early detection of acute kidney injury following elective nephron-sparing surgery: Preliminary results in a prospective cohort study 201
Mitochondria Permeability Transition versus Necroptosis in Oxalate-Induced AKI. 201
Effect of antimetabolite regimen on cellular and humoral immune response to SARS-COV-2 vaccination in solid organ transplant recipients 199
The presence of urinary renal progenitor cells in stable kidney transplant recipients anticipates allograft deterioration 198
Below Safety Limits, Every Unit of Glomerular Filtration Rate Counts: Assessing the Relationship Between Renal Function and Cancer-specific Mortality in Renal Cell Carcinoma 198
In vivo CD30 expression in human diseases with predominant activation of Th2-like T cells. 196
Modeled microgravity unravels the roles of mechanical forces in renal progenitor cell physiology 193
Stem-cell approaches for kidney repair: choosing the right cells 193
Expression of IP-10 and its receptor CXCR3 in hepatic stellate cells identifies a novel autocrine and paracrine system. 193
Renal Cancer Stem Cells: Characterization and Targeted Therapies 193
An update on human Th1 and Th2 cells 193
The use of lineage tracing to study kidney injury and regeneration 193
Human urine-derived renal progenitors for personalized modeling of genetic kidney disorders 193
Notch activation differentially regulates renal progenitors proliferation and differentiation toward the podocyte lineage in glomerular disorders. 191
The Role of Endothelial Progenitor Cells in Acute Kidney Injury 191
CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH2 cytokine production. 190
Fibrocytes in Chronic Periaortitis: A Novel Mechanism Linking Inflammation and Fibrosis 190
Novel strategies of regenerative medicine using chemical compounds 188
Heterogeneous genetic alterations in sporadic nephrotic syndrome associate with resistance to immunosuppression 187
Molecular Mechanisms of Renal Progenitor Regulation: How Many Pieces in the Puzzle? 187
Acute kidney injury 187
Assessment of chemokine receptor expression by human Th1 and Th2 cells in vitro and in vivo. 186
How much can the tubule regenerate and who does it? An open question 186
P1813CLINICAL CHARACTERIZATION OF CONGENITAL SOLITARY FUNCTIONING KIDNEY IN CHILDREN 186
Clinical-Grade Isolated Human Kidney Perivascular Stromal Cells as an Organotypic Cell Source for Kidney Regenerative Medicine 185
Lessons from genetics: is it time to revise the therapeutic approach to children with steroid-resistant nephrotic syndrome? 184
Peripheral blood as a source of stem cells for regenerative medicine 183
Renal cell carcinoma metastatic to the breast and breast cancer metastatic to the kidney: two rare solitary metastases. 183
Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury. 183
High CXCL10 expression in rejected kidneys and predictive role of pretransplant serum CXCL10 for acute rejection and chronic allograft nephropathy. 181
Stem cell therapy for kidney disease 179
Age-dependent changes in CXC chemokine ligand 10 serum levels in euthyroid subjects 179
Role of Sex Hormones in Prevalent Kidney Diseases 178
Localization of endothelin-converting enzyme-1 in human kidney 178
Acromegaly in Lorenzo the Magnificent, father of the Renaissance 178
Cell cycle-dependent expression of CXC chemokine receptor 3 by endothelial cells mediates angiostatic activity 178
Tubular cell polyploidy protects from lethal acute kidney injury but promotes consequent chronic kidney disease 178
Prognostic Factors and Long-Term Outcome with ANCA-Associated Kidney Vasculitis in Childhood 177
Angiotensin II stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells. 177
Lung ultrasound: a novel technique for detecting fluid overload in children on dialysis 177
Macrophage-derived chemokine production by activated human T cells in vitro and in vivo: preferential association with the production of type 2 cytokines. 176
Novel Biomarkers for Early Detection of Acute Kidney Injury and Prediction of Long-Term Kidney Function Decline after Partial Nephrectomy 173
Predictive Role of Pretransplant Serum CXCL10 for Cardiac Acute Rejection 173
Inflammatory response in human skeletal muscle cells: CXCL10 as a potential therapeutic target. 172
Production of IL-4 and leukemia inhibitory factor by T cells of the cumulus oophorus: a favorable microenvironment for pre-implantation embryo development. 172
IFN-αand IFN-β Specifically Affect Renal Progenitors and Podocytes In-Vitro and In-Vivo 171
Type I interferon-related kidney disorders 170
Sex and gender differences in kidney cancer: Clinical and experimental evidence 169
Totale 22.824
Categoria #
all - tutte 126.265
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 126.265


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.799 0 157 191 72 117 65 94 128 96 78 320 481
2022/20234.502 446 858 196 321 316 793 563 223 418 34 143 191
2023/20241.722 78 174 298 93 97 258 71 358 39 102 83 71
2024/202511.393 412 1.184 738 1.811 3.300 1.216 189 608 688 358 441 448
2025/202615.413 1.435 1.818 1.075 1.029 1.707 709 2.020 923 1.219 1.001 514 1.963
2026/20271.099 553 546 0 0 0 0 0 0 0 0 0 0
Totale 45.205